Black Rock Inc. Relay Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,542,667 shares of RLAY stock, worth $29.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,542,667
Previous 9,796,210
7.62%
Holding current value
$29.6 Million
Previous $81.3 Million
15.46%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
220Shares Held
163MCall Options Held
153KPut Options Held
49.2K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$78.4 Million0.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$34 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.8MShares$30.4 Million0.07% of portfolio
-
Casdin Capital, LLC New York, NY9.1MShares$25.6 Million2.79% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$22.7 Million1.37% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $338M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...